|
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
|
5R01CA210125-02
|
$656,491
|
|
WOODALL, W
|
KLEIN BUENDEL, INC.
|
|
Weakened spindle checkpoint in vivo: a cause of aneuploidy and cancer in FA?
|
5F30CA200227-02
|
$49,044
|
|
CERABONA, DONNA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Validation of FOXM1 as a new therapeutic target in high-risk myeloma
|
5R21CA187388-02
|
$165,844
|
|
JANZ, SIEGFRIED
|
UNIVERSITY OF IOWA
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-04
|
$379,294
|
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using markers to improve pancreatic cancer screening and surveillance
|
5U01CA210170-02
|
$953,081
|
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Understanding Uncertainties in Radiomics Studies
|
1R21CA216572-01
|
$174,000
|
|
COURT, LAURENCE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Transforming The Treatment of Tobacco Use in Health Care: Seizing The Potential of the Electronic Health Record to Deliver Comprehensive Chronic Care Treatment for Smoking
|
5R35CA197573-03
|
$888,930
|
|
FIORE, MICHAEL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Training Physician Scientists in Pediatric Oncology
|
5T32CA009659-22
|
$136,153
|
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Training In Cancer Biology
|
5T32CA009135-40
|
$424,344
|
|
SUGDEN, WILLIAM
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Training Grant in Cancer Biology
|
5T32CA186892-02
|
$223,492
|
|
HUNG, MIEN-CHIE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The role of FOXO transcriptional factors in TSC-mediated tumorigenesis
|
1R21CA135057-01
|
$171,000
|
$85,500
|
DePinho, Ronald
|
DANA-FARBER CANCER INSTITUTE
|
|
The Role of FKBP38 in tumorigenesis associated with Tsc deficiency
|
1R01CA129821-01A1
|
$281,526
|
$281,526
|
JIANG, YU
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
The mTOR and Hippo pathway in cell growth and cancer
|
5R35CA196878-03
|
$912,964
|
|
GUAN, KUN-LIANG
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma
|
1R01CA207031-01A1
|
$366,000
|
|
CHIAO, PAUL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Targeting sphingosine kinase 2 for the treatment of multiple myeloma
|
5R01CA197792-03
|
$363,713
|
|
KANG, YUBIN
|
DUKE UNIVERSITY
|
|
Targeting epigenetic regulation to disrupt glioma stem cell maintenance.
|
5F30CA183510-04
|
$49,044
|
|
MILLER, TYLER
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Targeting DNA Base Excision Repair in Acute Myeloid Leukemias
|
1R21CA216551-01
|
$200,970
|
|
LLOYD, R.
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Targeting cell metabolism for preventing and treating metastatic colon cancer
|
1R21CA216604-01
|
$172,913
|
|
JIN, SHENGKAN VICTOR
|
RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL
|
|
Targeting cancer-associated cohesin alterations
|
5F32CA203229-02
|
|
|
REGAL, JOSHUA
|
UNIVERSITY OF BRITISH COLUMBIA
|
|
Tailored NRT Integrated with Smartphone Behavioral Support
|
5R44CA199920-03
|
$1,000,000
|
|
LEVY, ALAN
|
CHRONO THERAPEUTICS, INC.
|
|
Study the mechanisms underlying common fragile site protection
|
5R01CA187052-03
|
$440,344
|
|
WU, XIAOHUA
|
SCRIPPS RESEARCH INSTITUTE
|
|
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses to hirsutinolides
|
1R01CA208851-01A1
|
$671,829
|
|
TURKSON, JAMES
|
UNIVERSITY OF HAWAII AT MANOA
|
|
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER
|
5P50CA127003-10
|
$2,293,187
|
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
Sphingosine-1-phosphate receptor subtype 3 in oncogenic K-Ras mutant-driven lung adenocarcinoma
|
1R21CA216650-01
|
$179,988
|
|
LEE, MENQ-JER
|
WAYNE STATE UNIVERSITY
|
|
Small Financial Incentives to Promote Smoking Cessation in Safety Net Hospital Patients
|
5R01CA197314-04
|
$303,797
|
|
KENDZOR, DARLA
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Six2 mediates late-stage metastasis through reversible/irreversible regulation of downstream target genes
|
5F31CA210622-02
|
$31,545
|
|
OLIPHANT, MICHAEL
|
UNIVERSITY OF COLORADO DENVER
|
|
Role of the Cell Cycle in Hypersensitivity to Estradiol
|
5R01CA084456-09
|
$325,345
|
$32,535
|
SANTEN, RICHARD
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Role of Slit in CXCR4-mediated breast cancer metastasis
|
5R01CA109527-10
|
$242,550
|
|
GANJU, RAMESH
|
OHIO STATE UNIVERSITY
|
|
Role of histone kinase VprBP in gene silencing: mechanisms, targets, and regulation
|
5R01CA201561-02
|
$377,438
|
|
AN, WOOJIN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Role of CX3CR1 in breast cancer metastasis
|
5R01CA202929-02
|
$357,994
|
|
FATATIS, ALESSANDRO
|
DREXEL UNIVERSITY
|
|
Repurposing statins to enhance efficacy of BCL-2 antagonists in blood cancer
|
5R21CA209341-02
|
$197,737
|
|
FRUMAN, DAVID
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Repurposing Metformin and Aspirin for Prostate Cancer Prevention and Control
|
5K07CA190541-03
|
$170,541
|
|
TAN, XIANGLIN
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
|
1R01CA129387-01A2
|
$319,260
|
$319,260
|
Brugarolas, James
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
Regulation of the mTOR growth pathway by nutrients
|
5R01CA103866-05
|
$369,317
|
$36,932
|
SABATINI, DAVID
|
WHITEHEAD INSTITUTE FOR BIOMEDICAL RES
|
|
Proteomics of Metastatic and Non-Metastatic Uveal Melanoma
|
1R21CA209500-01A1
|
$206,843
|
|
CRABB, JOHN
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Phosphodiesterase 10A, a novel target for lung cancer chemoprevention
|
5R01CA197147-02
|
$346,556
|
|
PIAZZA, GARY
|
UNIVERSITY OF SOUTH ALABAMA
|
|
Perinatal immune development and risk of childhood acute lymphoblastic leukemia
|
5R01CA175737-04
|
$675,204
|
|
WIEMELS, JOSEPH
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Pediatric Preclinical Testing Consortium: Coordinating Center
|
5U01CA199222-03
|
$467,618
|
|
ROWSHAN, SUDIE
|
RESEARCH TRIANGLE INSTITUTE
|
|
Pathologic and therapeutic implications of Akt attenuation in TSC cells and tumor
|
5R01CA122617-03
|
$255,599
|
$255,599
|
MANNING, BRENDAN
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
Pathogenesis of TSC2-Related Tumors
|
2R01CA077882-10A2
|
$355,095
|
$355,095
|
YEUNG, RAYMOND
|
UNIVERSITY OF WASHINGTON
|
|
Ovarian Cancer Chemoprevention
|
5R01CA196200-03
|
$500,225
|
|
BENBROOK, DORIS
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas
|
5R35CA197264-03
|
$636,627
|
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
Obesity and triple negative breast cancer; the role of hypercholesterolemia
|
5R01CA200553-02
|
$387,731
|
|
LEROITH, DEREK
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Neurotensin in Fibrolamellar Liver Cancer
|
5R21CA201867-02
|
$201,623
|
|
RIEHLE, KIMBERLY
|
UNIVERSITY OF WASHINGTON
|
|
Nanoscale Metal-organic Frameworks for Light Triggered and X-ray Induced Photodynamic Therapy of Head and Neck Cancers
|
5U01CA198989-03
|
$750,774
|
|
LIN, WENBIN
|
UNIVERSITY OF CHICAGO
|
|
Multicenter clinical trials for TSC & related disorders
|
5R01CA107164-04
|
$181,066
|
$181,066
|
DABORA, SANDRA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
mTOR-containing Protein Complexes in the Pathogenesis of Tuberous Sclerosis
|
5R01CA125436-02
|
$177,240
|
$88,620
|
Kristof, Arnold
|
MCGILL UNIVERSITY
|
|
MRI-Guided Dendritic-Cell-Based Vaccine Immunotherapy for Pancreatic Cancer
|
5R01CA209886-02
|
$352,556
|
|
ZHANG, ZHUOLI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Mouse Model of Pancreatic Tumorigenesis with Dysregulation of mTOR
|
1R03CA132103-01A1
|
$77,000
|
$77,000
|
FRAZIER, MARSHA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Molecular Pathogenesis of the Hamartoma Syndromes
|
5P01CA120964-02
|
$1,561,097
|
$1,561,097
|
KWIATKOWSKI, DAVID
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Tuberous Sclerosis for this search: $4,861,046
|